Rigel Pharmaceuticals Other Long Term Liabilities (Quarterly) Insights

Rigel Pharmaceuticals, Inc. (RIGL)

38.22 +0.26 (+0.68%) USD | NASDAQ | Jan 14, 12:34

View Other Long Term Liabilities (Quarterly) for RIGL.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Long Term Liabilities (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Long Term Liabilities (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Long Term Liabilities (Quarterly) Benchmarks

Start Trial

Nektar Therapeutics	Upgrade
Ironwood Pharmaceuticals, Inc.	Upgrade
Catalyst Pharmaceuticals, Inc.	Upgrade
Perspective Therapeutics, Inc.	Upgrade
Vertex Pharmaceuticals, Inc.	Upgrade